-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $23

Benzinga·07/22/2026 17:42:36
Listen to the news
Baird analyst Wesley Golladay maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and raises the price target from $22 to $23.